1-500 | 501-1000 | 1001-1052
     Part,  Chapter, Paragraph

   1    -,     1            |           enlargement to 25 countries in 2004 and to 27 countries in 2007,
   2    I,     2.  2        |                 than 700 billion euro in 2004 followed by the US, with
   3    I,     2.  2        |                  89%) into the EU during 2004 (Eurostat).~ ~The progressive
   4    I,     2.  2        |                 growing in Europe. Since 2004 global international arrivals
   5    I,     2.  2        |                56% in the period 1997 to 2004 and 26% in the opposite
   6    I,     2.  4        |                 members of the EU before 2004 and of those who joined
   7    I,     2.  4        |               those who joined the EU in 2004.~ ~Figure 2.2. Gross Domestic
   8    I,     2.  4        |           Employment and Social Affairs, 2004. As retired people generally
   9    I,     2.  5        |            provided for by the law.~ ~In 2004, the European Commission,
  10    I,     2.  6        |             ISCED levels 5 or 6) in 2003/2004~ ~This gap is evident throughout
  11    I,     2.  6        |               men (EUROSTAT, 2008).~ ~In 2004, women made up around 59%
  12    I,     2.  6        |              women than men graduated in 2004 in all countries except
  13    I,     2.  6        |                In the EU25 as a whole in 2004, 57% of those successfully
  14    I,     2.  6        |                  on average in the Eu in 2004, the opposite occurs in
  15    I,     2.  8        |                Negligible~ ~Source: WHO (2004)~ ~Many health outcomes
  16    I,     2. 10.  2    |                risks (The Royal Society, 2004; NIOSH, 2006; Schulte et
  17    I,     2. 11        |            Luxembourg~The Royal Society (2004): Nanoscience and nanotechnologies,
  18    I,     3.Acr        |                       Acronyms~ ~EUROPOP 2004 2004-based European Population
  19    I,     3.Acr        |                  Acronyms~ ~EUROPOP 2004 2004-based European Population
  20    I,     3.  2        |                 2). Based on the EUROPOP 2004 baseline population projections,
  21    I,     3.  2        |                 37%). According to GCIM (2004), the number of first-generation
  22    I,     3.  2        |                 put at 33 million (GCIM, 2004; HWWA 2004).~ ~During the
  23    I,     3.  2        |                million (GCIM, 2004; HWWA 2004).~ ~During the past 20 years,
  24    I,     3.  3        |            increased life expectancy. In 2004, Italy was the country with
  25    I,     3.  3        |                 observation period (2000-2004) is Germany. Whereas the
  26    I,     3.  3        |                  the period from 2000 to 2004. The recent value amounts
  27    I,     3.  3        |                value amounts to 26.8 for 2004, which corresponds to the
  28    I,     3.  4        |          International Migration (GCIM) (2004): GLOBAL MIGRATION PERSPECTIVES
  29    I,     3.  4        |             PERSPECTIVES No. 16, October 2004. Available at: htt ~ ~Hamburg
  30    I,     3.  4        |          International Economics (HWWA) (2004): Migrants in Europe and
  31   II,     4.Acr        |             Health Survey System~EUROPOP 2004~2004-based European Population
  32   II,     4.Acr        |               Survey System~EUROPOP 2004~2004-based European Population
  33   II,     4.  1        |                 Commission introduced in 2004, under the name of “Healthy
  34   II,     4.  1        |                 men) (Robine and Michel, 2004).~ ~Table 4.1.3 shows 10-
  35   II,     4.  1        |                Since its introduction in 2004 Healthy Life Years (HLY)
  36   II,     4.  3        |                  J.-M. and J.-P. Michel (2004): Looking forward for a
  37   II,     5.  1.  1    |              dementia (Haan and Wallace, 2004). Whilst a low level of
  38   II,     5.  2.  2    |                   Muller-Nordhorn et al, 2004] were published by the World
  39   II,     5.  2.  3    |           Society of Cardiology (ESC) in 2004 (Allender et al, 2008).
  40   II,     5.  2.  4    |              circumference (Yusuf et al, 2004) may play a more significant
  41   II,     5.  2.  4    |                CVD incidence (Wellman J, 2004).~Due to differences in
  42   II,     5.  2.  4    |                 INTERHEART (Yusuf et al, 2004) case-control study, conducted
  43   II,     5.  2.  5    |             guidelines (Grundy SM et al, 2004, Graham I et al, 2007)~Within
  44   II,     5.  2.  5    |                  Council Conclusion from 2004 (Council of the European
  45   II,     5.  2.  5    |           Council Meeting1 and 2 June 2004) on promoting cardiovascular
  46   II,     5.  2.  7    |              Stamler J, Pirzada A et al (2004): Favorable Cardiovascular
  47   II,     5.  2.  7    |                  P, Varigo J, Lisheng A (2004): Effect of potentially
  48   II,     5.  3.  3    |           geographical area from 1980 to 2004 as supplied by the WHO.~-
  49   II,     5.  3.  7    |                  stopped (Tsubono et al, 2004).~Ideally, an organised
  50   II,     5.  3.  7    |          Planning stage~NETHERLANDS~Yes (2004)~AUSTRIA~Yes (regional)~
  51   II,     5.  3.  9    |                  Tsubono Y, Hisamichi S (2004):. A halt to neuroblastoma
  52   II,     5.  4.  1    |               worldwide (King 1998; Wild 2004). In the past, this form
  53   II,     5.  4.  1    |               countries (King 1998; Wild 2004).~ ~Figure 5.4.1. The Growing
  54   II,     5.  4.  1    |           Epidemic~ ~(WHO Report, 6 May, 2004)~ ~A complex interaction
  55   II,     5.  4.  2    |               feasible (Greenfield et al 2004, see Table 5.4.2), only
  56   II,     5.  4.  2    |                  been included (Fleming, 2004).~In this case participants
  57   II,     5.  4.  6    |                 the EU Health Council in 2004, under the Irish Presidency,
  58   II,     5.  4.  6    |                  the Otocec Declaration (2004), signed by more than 80
  59   II,     5.  4.  8    |                Nicolucci A and Mattke S (2004): Selecting Indicators for
  60   II,     5.  4.  8    |                  10 October 2008)~Wil H (2004): Global prevalence of diabetes:
  61   II,     5.  5.Int(8) |                     European Commission (2004): The State of Mental Health
  62   II,     5.  5.Int(15)|                  deVries MW, Wilson KCM (2004): Depression among older
  63   II,     5.  5.Int(18)|                 Tsuboi K, Dennerstein L.(2004): Prevalence of eating disorders:
  64   II,     5.  5.Int    |               between social partners in 2004.~ ~The Community’s Framework
  65   II,     5.  5.Int(20)|                     European Commission (2004): Action for Mental Health.
  66   II,     5.  5.Int(20)|            Public health Programmes 1997-2004. htt m. A list of all completed
  67   II,     5.  5.  1    |                  suicide. For example in 2004 the total costs from depression
  68   II,     5.  5.  1    |               females) (Schmidtke et al, 2004).~ ~
  69   II,     5.  5.  1    |              depression” was prepared in 2004 by the Commission. The expert
  70   II,     5.  5.  1    |                 and Prevention Policies (2004- ) was especially targeted
  71   II,     5.  5.  1    |                  for the European level (2004-6), provided final set of
  72   II,     5.  5.  1    |            Public Health Programmes 1997-2004). Luxembourg: European Communities
  73   II,     5.  5.  1    |                  Communities and STAKES, 2004.~ ~European Commission (
  74   II,     5.  5.  1    |        depression. European Communities, 2004. Also available online at:
  75   II,     5.  5.  1    |          Bille-Brahe U, De Leo D et al. (2004). Suicidal behaviour in
  76   II,     5.  5.  2    |                 UK and Estonia were from 2004. Population statistics were
  77   II,     5.  5.  2    |              dementia (Haan and Wallace, 2004). Whilst a low level of
  78   II,     5.  5.  2    |                   Haan MN and Wallace R (2004): Can dementia be prevented?
  79   II,     5.  5.  3    |                 per decade (Misra et al, 2004; Gupta, 1995). Anorexia
  80   II,     5.  5.  3    |                  time in 2001/2002 (WHO, 2004). A lot of European Union (
  81   II,     5.  5.  3    |                 increases with age (WHO, 2004).~Berkman et al (2007) reviewed
  82   II,     5.  5.  3    |              anorectic or bulimic (NEDA, 2004):~· Psychological factors:
  83   II,     5.  5.  3    |              Herzog, D.B, Klibanski, A. (2004): Effects of Anorexia Nervosa
  84   II,     5.  5.  3    |                  Disorders Association) (2004): What Causes Eating Disorders?
  85   II,     5.  5.  3    |               World Health Organization (2004): Health Policy for Children
  86   II,     5.  5.  3    |             European Region (Kohn et al, 2004). Evidence indicates that
  87   II,     5.  5.  3    |                 installed (Häfner et al, 2004). During that time, dire
  88   II,     5.  5.  3    |               was 12 months (Kohn et al, 2004).~The percentage difference
  89   II,     5.  5.  3    |                   was 32.2% (Kohn et al, 2004) worldwide; selected data
  90   II,     5.  5.  3    |                  strategy (Demyttenaere, 2004; Middelboe, 2001).~While
  91   II,     5.  5.  3    |              based on the 1st quarter of 2004, second generation antipsychotics
  92   II,     5.  5.  3    |                Poland (Fricke and Pirck, 2004). Differences in usage of
  93   II,     5.  5.  3    |              Mental Health Surveys (WHO, 2004), which were linked to the
  94   II,     5.  5.  3    |             ESEMeD) (Demyttenaere et al, 2004). The authors concluded
  95   II,     5.  5.  3    |                  Spain and Ukraine (WHO, 2004). While the need for treatment
  96   II,     5.  5.  3    |      Andlin-Sobocki & Rössler, 2005).~In 2004, the costs for hospital
  97   II,     5.  5.  3    |                service for year 2002 and 2004 with respect to F20-F29~
  98   II,     5.  5.  3    |           telephone surveys from 2001 to 2004. Nervenarzt Apr 4; Epub
  99   II,     5.  5.  3    |                Health Survey Consortium (2004): Prevalence, severity,
 100   II,     5.  5.  3    |                252-259.~Fricke and Pirk (2004): Defizite in der Arzneimittelversorgung
 101   II,     5.  5.  3    |                  HJ, Gaebel W, Wölwer W (2004): Early detection and secondary
 102   II,     5.  5.  3    |                  S, Levav I, Saraceno B (2004): The treatment gap in mental
 103   II,     5.  5.  3    |                Health Survey Consortium (2004): Prevalence, severity,
 104   II,     5.  5.  3    |        comparisons. A study published in 2004 (Blaxill, 2004) looks at
 105   II,     5.  5.  3    |              published in 2004 (Blaxill, 2004) looks at the different
 106   II,     5.  5.  3    |                 References~ ~Blaxill MF (2004): What’s Going On? The Question
 107   II,     5.  5.  3    |          treatment initiation (Forsgren, 2004). Active epilepsy is defined
 108   II,     5.  5.  3    |              vary from 25 to 51% (Beghi, 2004). The main etiological factors
 109   II,     5.  5.  3    |                  Modified from Forsgren, 2004 and Forsgren et al., 2005~ ~
 110   II,     5.  5.  3    |            adults. As shown by Forsgren (2004) in prevalence studies made
 111   II,     5.  5.  3    |             children and adults (Jallon, 2004) (Table 5.5.3.4.4). These
 112   II,     5.  5.  3    |               incidence cohorts (Jallon, 2004).~These rates were not significantly
 113   II,     5.  5.  3    |              between 7 and 50 (Forsgren, 2004). Remote symptomatic seizures
 114   II,     5.  5.  3    |                 6 (Gaitatzis and Sander, 2004). Patients with epilepsy
 115   II,     5.  5.  3    |           seizure-related (Tomson et al, 2004). In these populations,
 116   II,     5.  5.  3    |              unstable treatment (Jallon, 2004). SUDEP is rare in community-based
 117   II,     5.  5.  3    |                  from 4.5 to 32 (Jallon, 2004). In a population-based
 118   II,     5.  5.  3    |               epilepsy (Gaitatzis et al, 2004). Records were taken of
 119   II,     5.  5.  3    |               Database (Gaitatzis et al, 2004). The ICD-9 coding system
 120   II,     5.  5.  3    |           children was 74-78% (Forsgren, 2004). In the Finnish cohort
 121   II,     5.  5.  3    |                  epilepsy (Jacoby et al, 2004). In addition, unemployment
 122   II,     5.  5.  3    |                 Van den Broek and Beghi, 2004). Intervention studies on
 123   II,     5.  5.  3    |                  Lay, 1997; Sheth et al, 2004). In addition, mandatory
 124   II,     5.  5.  3    |           License Committee of the EU in 2004. This group, which was represented
 125   II,     5.  5.  3    |         Epilepsia 43:1076-1083.~Beghi E (2004): Aetiology of epilepsy.
 126   II,     5.  5.  3    |                  37:224-229.~Forsgren L (2004): Epidemiology and prognosis
 127   II,     5.  5.  3    |                  Gaitatzis A, Sander JW (2004): The mortality of epilepsy
 128   II,     5.  5.  3    |                  K, Majeed A, Sander JW (2004): The epidemiology of the
 129   II,     5.  5.  3    |             Gorry J, Gamble C, Baker GA (2004): Public knowledge, private
 130   II,     5.  5.  3    |                  45:1405-1415.~Jallon P (2004): Mortality in patients
 131   II,     5.  5.  3    |              Krauss G, Krumholz A. Li G (2004): Mortality in epilepsy:
 132   II,     5.  5.  3    |             Sundqvist A, Johannessen SI (2004): Medical risks in epilepsy:
 133   II,     5.  5.  3    |                 E, for the RESt-1 group (2004): Accidents in patients
 134   II,     5.  5.  3    |                higher MS incidence (WHO, 2004), thus proportional greater
 135   II,     5.  5.  3    |                 vs 38%) (Fangerau et al, 2004).~Lastly, the lack of “attacks”
 136   II,     5.  5.  3    |              Sclerosis (Battaglia et al, 2004).~These recommendations
 137   II,     5.  5.  3    |        References~ ~Bajenaru O, Pascu I (2004): Report of multiple sclerosis
 138   II,     5.  5.  3    |           Ketelaer P, Thompson A et al; (2004): Recommendations on Rehabilitation
 139   II,     5.  5.  3    |                 98:238-242.~Berkowicz T (2004): Report of multiple sclerosis
 140   II,     5.  5.  3    |            Koch-Henriksen N, Stenager E (2004): Trends in survival and
 141   II,     5.  5.  3    |                 KM, Nyland H, Midgard R (2004): Multiple sclerosis in
 142   II,     5.  5.  3    |                   Ekestern E, Lebhart G (2004). Mortality from multiple
 143   II,     5.  5.  3    |            European Governments on-line (2004): Available at: www tm Accessed
 144   II,     5.  5.  3    |                          Accessed Sept 6 2004.~Fangerau T, Schimrigk S,
 145   II,     5.  5.  3    |            Schimrigk S, Haupts M, et al (2004): Diagnosis of multiple
 146   II,     5.  5.  3    |                 56(2):78-105~Horakova D (2004): Report of multiple sclerosis
 147   II,     5.  5.  3    |            McCarthy A, Quigley C, et al (2004): Latitudinal variation
 148   II,     5.  5.  3    |                  C, Baldwin D, Mayers A (2004). Changing patterns of adult (
 149   II,     5.  5.  3    |           Wikström J, Paltamaa J, et al (2004): Occurrence of multiple
 150   II,     5.  5.  3    |        Svenningsson A, Nyström L, et al (2004): Clinical characteristics
 151   II,     5.  5.  3    |         Estimates. In: WHO Health Report 2004.~World Health Organization (
 152   II,     5.  5.  3    |                  The world health report 2004 - changing history. WHO,
 153   II,     5.  5.  3    |                  2003; Bergareche et al, 2004; Chio et al, 1998; DAlessandro
 154   II,     5.  5.  3    |                EUGLOREH countries (€PPP, 2004)~ ~The total cost of PD
 155   II,     5.  5.  3    |            estimated at €10.7 billion in 2004 in EU25 and EFTA countries.
 156   II,     5.  5.  3    |               and Tranchant, 2007; Quik, 2004; Chade et al 2006). However,
 157   II,     5.  5.  3    |                  al, 1999; Gorell et al, 2004).~ ~
 158   II,     5.  5.  3    |                European Commission, 2001-2004 (htt . EuroPa aimed at establishing
 159   II,     5.  5.  3    |             disease. (EuroPa Consortium, 2004)~The European Brain Council (
 160   II,     5.  5.  3    |                 Poza JJ, Marti-Masso JF (2004): Prevalence of Parkinson’
 161   II,     5.  5.  3    |                  604.~EuroPa Consortium (2004): A European Network for
 162   II,     5.  5.  3    |                  Rybicki BA, Johnson CC (2004): Multiple risk factors
 163   II,     5.  5.  3    |             Available at: htt f.~Quik M (2004): Smoking, nicotine and
 164   II,     5.  6.  2    |               2005 (European Commission (2004): European Action Towards
 165   II,     5.  6.  3    |      participation (European Commission (2004): European Action Towards
 166   II,     5.  6.  3    |                et al, 1999; Woolf et al, 2004). Musculoskeletal conditions
 167   II,     5.  6.  3    |         disability (European Commission (2004): European Action Towards
 168   II,     5.  6.  3    |         disability (European Commission (2004): European Action Towards
 169   II,     5.  6.  3    |                 al, 1993; Johnell et al, 2004).~ ~Future trends~ ~The
 170   II,     5.  6.  5    |             Health (European Commission (2004): European Action Towards
 171   II,     5.  6.  6    |                     European Commission (2004): European Action Towards
 172   II,     5.  6.  6    |                 C, De Laet C, Jonsson B (2004): Mortality after osteoporotic
 173   II,     5.  6.  6    |                 Veale DJ, Martin-Mola E (2004): Musculoskeletal pain in
 174   II,     5.  7.  1    |          Organization, 2005; Yach et al, 2004). However, it is exceedingly
 175   II,     5.  7.  1    |                  obesity (Rodgers et al, 2004) and consume a large fraction
 176   II,     5.  7.  1    |                 in the USA (Smith et al, 2004). A considerable amount
 177   II,     5.  7.  3    |                pmarp) (Ardissino et al., 2004). In the Swedish study (
 178   II,     5.  7.  3    |             observed for CKD (Hsu et al, 2004). Indeed, 9 new cases of
 179   II,     5.  7.  3    |                 fruit (Gansevoort et al, 2004; Stewart et al, 2006). The
 180   II,     5.  7.  3    |                   Van der Heijden et al, 2004). In 2005 the prevalence
 181   II,     5.  7.  3    |             evolution to ESRD (Go et al, 2004) - in population-based studies
 182   II,     5.  7.  3    |               1988-1994 and between 1999-2004 respectively). In those
 183   II,     5.  7.  3    |                 fruit (Gansevoort et al, 2004; Stewart et al, 2006). The
 184   II,     5.  7.  5    |           assessed at regional level. In 2004 the French Ministry of Health
 185   II,     5.  7.  7    |          Nieuwenhuizen MG, de ZD, et al (2004): Trends in the incidence
 186   II,     5.  7.  7    |                 future? Kidney Int Suppl 2004 Nov;(92):S7-10.~Gansevoort
 187   II,     5.  7.  7    |                 D, McCulloch CE, Hsu CY (2004): Chronic kidney disease
 188   II,     5.  7.  7    |            hospitalization. N Engl J Med 2004 Sep 23;351(13):1296-305.~
 189   II,     5.  7.  7    |        Vittinghoff E, Lin F, Shlipak MG (2004): The incidence of end-stage
 190   II,     5.  7.  7    |            insufficiency. Ann Intern Med 2004 Jul 20;141(2):95-101.~Jager
 191   II,     5.  7.  7    |                 disease. Am J Kidney Dis 2004;43(Suppl 1):S1-S290.~Obrador
 192   II,     5.  7.  7    |             Lopez AD, Lin RB, Murray CJ (2004): Distribution of major
 193   II,     5.  7.  7    |           Nichols G, Keith DS, Brown JB (2004): Cost of medical care for
 194   II,     5.  7.  7    |             population. J Am Soc Nephrol 2004 May;15(5):1300-6.~Stengel
 195   II,     5.  8.  2    |             reported asthma (Viegi et al 2004).~ ~Table 5.8.2.1. ICD10
 196   II,     5.  8.  3    |              guidelines (De Marco et al, 2004). These results are reported
 197   II,     5.  8.  3    |            patients with COPD (Rea et al 2004; GOLD 2006)~ ~A relevant
 198   II,     5.  8.  3    |            Amsterdam by Kriegsman et al (2004), apart from observing that
 199   II,     5.  8.  3    |                study by Mikkelsen et al (2004) found that clinical significant
 200   II,     5.  8.  3    |                 a study by Wagena et al (2004) smoker patients with asthma
 201   II,     5.  8.  3    |                 study by Sprenkle et al (2004), SF-36V was used in a large
 202   II,     5.  8.  3    |            consumption (Detournay et al, 2004). Moreover, the costs increased
 203   II,     5.  8.  3    |               909€ in Spain (Masa et al, 2004) and 1 261€ in Italy.~ ~
 204   II,     5.  8.  4    |            respectively (De Marco et al, 2004).~ ~In a review of community
 205   II,     5.  8.  4    |                  workers (Bergahl et al, 2004). In the European Community
 206   II,     5.  8.  5    |          guidelines have been issued: in 2004 by the American Thoracic
 207   II,     5.  8.  5    |              Society (ERS) (Celli et al, 2004), which is updated every
 208   II,     5.  8.  7    |                Flodin R, and Järvholm B (2004): Increased mortality in
 209   II,     5.  8.  7    |             position paper. Eur Respir J 2004; 23: 932-946.~ ~Cerveri
 210   II,     5.  8.  7    |             Svanes C, Anto JM, Burney P (2004): European Community Respiratory
 211   II,     5.  8.  7    |         according to GOLD stages. Thorax 2004; 59: 120125.~ ~Detournay
 212   II,     5.  8.  7    |           Jourdanne C, Durand-Zaleski I (2004): SCOPE Group. The SCOPE
 213   II,     5.  8.  7    |                  in France. Value Health 2004; 7: 168-174.~ ~European
 214   II,     5.  8.  7    |                 DM, Deeg DJ, Stalman WA (2004): Comorbidity of somatic
 215   II,     5.  8.  7    |              Amsterdam. J Clin Epidemiol 2004; 57: 55-65.~ ~Lindberg A,
 216   II,     5.  8.  7    |                Viejo JL, Miravitlles M. (2004):Costs of chronic obstructive
 217   II,     5.  8.  7    |                 T, Pisinger C, Stage KB (2004): Anxiety and depression
 218   II,     5.  8.  7    |                review. Nord J Psychiatry 2004; 58: 65-70.~ ~Miravitlles
 219   II,     5.  8.  7    |                   Roseman P, Didsbury P (2004): A chronic disease management
 220   II,     5.  8.  7    |          pulmonary disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
 221   II,     5.  8.  7    |                DE, Nelson DB, Nichol KL (2004): The Veterans Short Form
 222   II,     5.  8.  7    |                 of asthma or COPD. Chest 2004; 126: 81-89.~ ~Stratelis
 223   II,     5.  8.  7    |               Molstad S, Zetterstrom O. (2004): Early detection of COPD
 224   II,     5.  8.  7    |                 55 years. Br J Gen Pract 2004; 54: 201-206.~ ~Sunyer J,
 225   II,     5.  8.  7    |                  Soriano JB, Carrozzi L (2004): The proportionalVenn diagram
 226   II,     5.  8.  7    |                general population. Chest 2004; 126; 1093-1101.~ ~V . (
 227   II,     5.  8.  7    |              cigarettes. Eur J Epidemiol 2004; 19: 147-53.~ ~Zielinski
 228   II,     5.  9.  2    |                    ECRHS) (Burney et al, 2004).~ ~ISAAC started in 1991.
 229   II,     5.  9.  2    |                    ECRHS) (Burney et al, 2004) was set up in 1993 and
 230   II,     5.  9.  2    |                 January 2000 and 15 June 2004 (tables 5.9.5 to 5.9.7).
 231   II,     5.  9.  3    |                    ECRHS) (Burney et al, 2004) have shown once again that
 232   II,     5.  9.  4    |                 047), 1999 (n=3,540) and 2004 (n=1,920) in school-children
 233   II,     5.  9.  4    |                 RR 1.20 (0.99, 1.45). By 2004 this sex bias in diagnosis
 234   II,     5.  9.  4    |                  hay fever. From 1989 to 2004 no significant difference
 235   II,     5.  9.  4    |           person-yrs(-1)). (Torén et al, 2004).~ ~ ~Some environmental
 236   II,     5.  9.  4    |               hay-fever) (Ventura et al, 2004). A large cross-sectional
 237   II,     5.  9.  7    |              Austin JB, Burr M, Jeffs D (2004): Trends in prevalence of
 238   II,     5.  9.  7    |                Questionnaire survey. BMJ 2004; 328:1052-1053.~ ~Baiardini
 239   II,     5.  9.  7    |                 60:165-170~ ~Burney PGJ (2004): The European Community
 240   II,     5.  9.  7    |            Initiative for Asthma (GINA) (2004): The global burden of asthma:
 241   II,     5.  9.  7    |                  Suppl):S2-8.~ ~Torén K (2004): A prospective study of
 242   II,     5.  9.  7    |                RHINE study. Eur Respir J 2004; 24: 942-946~ ~To E, Tosca-Segura
 243   II,     5.  9.  7    |               Europe, 1997~ ~Ventura MT (2004): Allergy, asthma and markers
 244   II,     5.  9.  7    |                  Southern Italy. Allergy 2004; 59:632-636~ ~Verlato G,
 245   II,     5. 10.  1    |                food.~(Adapted from EFSA, 2004 and INFOSAN, 2006)~ ~ ~ ~
 246   II,     5. 10.  1    |                  4-6% in children (EFSA, 2004).~ ~Health consequences
 247   II,     5. 10.  1    |            central nervous system (EFSA, 2004). As for allergies in general,
 248   II,     5. 10.  1    |                  group considered (EFSA, 2004). A partial explanation
 249   II,     5. 10.  1    |                in children (Mills et al, 2004).~ ~
 250   II,     5. 10.  2    |                 Woods et al, 2002; EFSA, 2004). Finally, allergic reactions
 251   II,     5. 10.  2    |                labelling purposes (EFSA, 2004), which is the most updated
 252   II,     5. 10.  3    |                latter (Løvik and Narmok, 2004). In adults, main foods
 253   II,     5. 10.  3    |                background factors (EFSA, 2004).~Although very few longitudinal
 254   II,     5. 10.  7    |                 Safety Authority (EFSA) (2004): Opinion of the Scientific
 255   II,     5. 10.  7    |               378.~Løvik M and Namork N (2004): The Norwegian reporting
 256   II,     5. 10.  7    |                  P, Crevel RW, Frewer L (2004): Information provision
 257   II,     5. 11.  3    |                 prevention,. In the year 2004, altogether 11,643 patients
 258   II,     5. 11.  3    |             testing the standard series, 2004. Journal of the European
 259   II,     5. 11.  3    |        populations (van Coevorden et al, 2004).~ ~Psoriasis~Psoriasis
 260   II,     5. 11.  3    |               Mahler, 2002; Boyle et al, 2004).~ ~Non-Melanoma skin cancer~
 261   II,     5. 11.  5    |          Conference, held in Budapest in 2004, the WHO Regional Office
 262   II,     5. 11.  7    |                JF, Autier P, Ringborg U (2004): Cancer of the skin: a
 263   II,     5. 11.  7    |             problem in Europe. Ann Oncol 2004;15(1):5-6.~ ~Boyle P, Smans
 264   II,     5. 11.  7    |                 AM, Coenraads PJ, et al (2004) ; Overview of studies of
 265   II,     5. 11.  7    |        hand-eczema survey. Br J Dermatol 2004;151(2):446-51.~ ~Verboom
 266   II,     5. 12.  5    |                et al, 2000; Negri et al, 2004; Shepard et al, 2005).~ ~ ~ ~
 267   II,     5. 12.  7    |                 Vecchia C, Franceschi S (2004): B-cell non-Hodgkin's lymphoma
 268   II,     5. 13        |                 inactivity (James et al, 2004; WHO, 2002; WHO Regional
 269   II,     5. 13        |                  EU15 (EU members before 2004) were estimated to be €32.
 270   II,     5. 14.  2    |       adolescents and adults (Bourgeois, 2004). In Scandinavia, oral health
 271   II,     5. 14.  3    |                country (Wid m and Eaton, 2004).~In 2000, expenditures
 272   II,     5. 14.  8    |                 Bourgeois DM, Llodra JC (2004): eds. Health Surveillance
 273   II,     5. 14.  8    |              Quintessence Publishing Co. 2004:8192.~Bourgeois DM (2004):
 274   II,     5. 14.  8    |                2004:8192.~Bourgeois DM (2004): European Global Oral Health
 275   II,     5. 14.  8    |                 2007; 369: 5159.~Wid A (2004): Oral healthcare systems
 276   II,     5. 14.  8    |                   Oral Health Prev Dent. 2004; 2:155-94.~World Health
 277   II,     5. 15.  1    |                  van Weely and Leufkens, 2004; Wastfelt et al, 2004).
 278   II,     5. 15.  1    |          Leufkens, 2004; Wastfelt et al, 2004). Among the most common
 279   II,     5. 15.  3    |                prices were set (ALCIMED, 2004). Several articles have
 280   II,     5. 15.  4    |                 EC and Regulation No 726/2004, adopted (in first reading)
 281   II,     5. 15.  4    |             Public Health established in 2004 a Rare Diseases Task Force
 282   II,     5. 15.  6    |                 6. References~ ~ALCIMED (2004): Study on Orphan Drugs.
 283   II,     5. 15.  6    |               and Regulation (EC) No 726/2004. Available at: htt L (accessed
 284   II,     5. 15.  6    |               Van Weely S, Leufkens HGM (2004): Orphan Diseases in “Priority
 285   II,     6.  2        |                trends for the years 199520041. This information is complemented
 286   II,     6.  3.  1    |             population of 16 million) in 2004 the cost attributable to
 287   II,     6.  3.  3    |                cases in 1996 to 6 386 in 2004. This increase is largely
 288   II,     6.  3.  3    |                cases in 2001 to 4 151 in 2004. The number of newly diagnosed
 289   II,     6.  3.  3    |               from 1 491 to 860 cases in 2004), although data are unavailable
 290   II,     6.  3.  3    |              trends over the period 19952004 were observed in the Nordic
 291   II,     6.  3.  3    |                  Europe has again, since 2004, been noted in several large
 292   II,     6.  3.  3    |                  per 100 000 per year in 2004. In the low-incidence countries
 293   II,     6.  3.  3    |         Gonorrhoea within the EU, 1995 - 2004~ ~Syphilis~ ~Syphilis significantly
 294   II,     6.  3.  3    |                  per 100 000 per year in 2004, mainly due to outbreaks
 295   II,     6.  3.  3    |                was observed from 1996 to 2004. In some central European
 296   II,     6.  3.  3    |                  per 100 000 per year in 2004, but this increase may possibly
 297   II,     6.  3.  4    |              public health threat.~ ~The 200405 influenza season in Europe
 298   II,     6.  3.  4    |                 started in late December 2004 with the first influenza
 299   II,     6.  3.  4    |                  influenza strain of the 200405 and 200506 winter seasons
 300   II,     6.  3.  4    |             Cases of TB between 1995 and 2004~ ~ ~ ~Table 6.A1.3 Cases
 301   II,     6.  3.  4    |            Europe which joined the EU in 2004, where TB rates are moderate,
 302   II,     6.  3.  4    |                  of legionellosis 1995 - 2004.~ ~The incidence of legionellosis
 303   II,     6.  3.  5    |                 in Europe between 1995 - 2004.~ ~This drop is mainly due
 304   II,     6.  3.  5    |               notably Poland in 1998 and 2004, Estonia in 1998, France
 305   II,     6.  3.  6    | Campylobacteriosis trends between 1995 - 2004~ ~In 2005, more than 200
 306   II,     6.  3.  6    |              increase in incidence since 2004 . This could be due to improved
 307   II,     6.  3.  6    |                by Italy between 1995 and 2004 (6 440 cases). In 2005,
 308   II,     6.  3.  6    |                  trend. The incidence in 2004 (0.28 per 100 000 per year)
 309   II,     6.  3.  6    |             cases (0.87 per 100 000)) to 2004 (1 743 cases (0.38 per 100
 310   II,     6.  3.  6    |                  Europe between 1995 and 2004, and during this period
 311   II,     6.  3.  6    |                  declined steadily until 2004~In 2005, a total of 21 cases
 312   II,     6.  3.  7    |                EU during the period 19952004, ranging from 0.1 to 0.22
 313   II,     6.  3.  7    |              years (687) was reported in 2004. France continues to report
 314   II,     6.  4.  4    |            founding Regulation EC  851/2004, the ECDC plays a key role
 315   II,     7.  2.  4    |                 being the reference year 2004.~htt ~ ~
 316   II,     7.  2.  7    |                         was developed in 2004 by an EU-funded project
 317   II,     7.  3.  2    |           Standardised Death Rates (1995-2004, Index = 1995), EU27~ ~
 318   II,     7.  3.  4    |             definition according to WHO, 2004) and 1.7 million injured
 319   II,     7.  3.  5    |               suicide (Guo and Harstall, 2004).~ ~Globally seen, in modern
 320   II,     7.  4.  2    |                 report by Todd & Skelton 2004, the policy guidelinePriorities
 321   II,     7.  4.  3    |                 cyclists) were killed in 2004 (Working Group of Governmental
 322   II,     7.  4.  6    |            strategies (Guo and Harstall, 2004).~ ~
 323   II,     7.  5        |               WHO, 2007; Racioppi et al, 2004). The areas of action are
 324   II,     7.  5        |                collection (Holder et al, 2004). Through a series of projects,
 325   II,     7.  7        |                  HU, LV, NL, PT, SI, SE (2004) EE, IT (2003) [https://
 326   II,     7.  7        |              2008].~ ~Guo B, Harstall C (2004). For which strategies of
 327   II,     7.  7        |                Tingvall C, Villaveces A (2004): Preventing Road Traffic
 328   II,     7.  7        |            Europe.~ ~Todd C, Skelton D. (2004): What are the main risk
 329   II,     7.  7        |               Health Organization (WHO) (2004): World Report on Road Traffic
 330   II,     8.  1.  2    |                 first data collection in 2004. This survey covers only
 331   II,     8.  1.  5    |                phase of the Action Plan (2004-2005) addressed the establishment
 332   II,     8.  1.  5    |             priorities for action during 2004-2005. The second phase of
 333   II,     8.  2.  1    |                  funded by DG-SANCO 2002-2004, concluded (Linehan et al
 334   II,     8.  2.  1    |                 concluded (Linehan et al 2004). However, some countries –
 335   II,     8.  2.  1    |                  Rowe1998; Mason & Scior 2004). Visual and dental care
 336   II,     8.  2.  1    |               behavioural issues (Fisher 2004).~Arguably, stigmatisation
 337   II,     8.  2.  1    |                51, 866-874.~Fisher, K., (2004). Health Disparities and
 338   II,     8.  2.  1    |               Scholarship, First Quarter 2004, 48-53~Fujiura, G.T., Park,
 339   II,     8.  2.  1    |                 Mason, J., & Scior, K., (2004). Diagnostic overshadowing
 340   II,     8.  2.  2    |             impairment (Pascolini et al, 2004) is an important source
 341   II,     8.  2.  2    |               the EU SILC carried out in 2004. The results obstained with
 342   II,     8.  2.  2    |                  out by Resnikoff et al (2004). Prevalence of blindness
 343   II,     8.  2.  2    |               Iceland) (Resnikoff et al, 2004). Estimates for Bulgaria
 344   II,     8.  2.  2    |                  out by Resnikoff et al (2004). Prevalence of blindness
 345   II,     8.  2.  2    |               Iceland) (Resnikoff et al, 2004). Estimates for Bulgaria
 346   II,     8.  2.  2    |                new Member States (Kocur, 2004)~ ~
 347   II,     8.  2.  2    |           Epidemiology 6:73-82.~Kocur I (2004): Fifteen years of eye health
 348   II,     8.  2.  2    |               ale D, Négrel A-D, et al. (2004): 2002 Global update of
 349   II,     8.  2.  2    |             Pokharel GP and Mariotti SP (2004): Global data on visual
 350   II,     8.  2.  2    |         uncorrected refractive errors in 2004 Bulletin of the World Health
 351   II,     8.  2.  3    |               the EU SILC carried out in 2004. The results obtained with
 352   II,     8.  2.  3    |             Living Conditions (EU-SILC) (2004): Database available at: htt ~ ~
 353   II,     9            |         morbidity (Maher and Macfarlane, 2004). Older mothers and nulliparas
 354   II,     9            |             stillbirth (Canterino et al, 2004; Raymond et al, 1994; Reddy
 355   II,     9            |                  and Brown, 2007b; Magee 2004). This increased risk is
 356   II,     9            |                  al, 2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.
 357   II,     9            |                et al, 1999; Cnattingius, 2004). These effects concern
 358   II,     9            |        congenital anomaly risk (EUROCAT, 2004; Macintosh et al, 2006),
 359   II,     9            |                   Waller, 2007; EUROCAT, 2004). In the case of epilepsy
 360   II,     9            |                 Vrijheid, 2003; EUROCAT, 2004). To protect the fetus,
 361   II,     9            |                1996; Matharu and Ozanne, 2004; Ozanne et al, 2004).~ ~
 362   II,     9            |              Ozanne, 2004; Ozanne et al, 2004).~ ~Smoking. Smoking is
 363   II,     9            |                 society's terms (Jarvis, 2004). Data from ESPAD from 16
 364   II,     9            |              peaks in Denmark (WHO/HSBC, 2004; www rg interactive data) (
 365   II,     9            |               and Switzerland (WHO/HSBC, 2004), though in ESPAD data the
 366   II,     9            |                 sexual health (WHO/HSBC, 2004).~ ~Inadequate physical activity.
 367   II,     9            |                 media pressure (WHO/HSBC 2004). Although varying widely
 368   II,     9            |                 during the day (WHO/HSBC 2004).~ ~Disability. Regrettably,
 369   II,     9            |               behaviors (De Groot et al, 2004). Member States should consider
 370   II,     9            |          important risk factor (WHO/HEN, 2004).~ ~References cited in
 371   II,     9.  1.  1    |             current EU Member States. By 2004, they ranged from 1.6 to
 372   II,     9.  1.  1    |                 of neonatal mortality in 2004 was 2.7 per 1 000 births.
 373   II,     9.  1.  1    |          countries that joined the EU in 2004 (Czech Republic, Cyprus,
 374   II,     9.  1.  1    |            greater downward trend. Using 2004 data, there was no difference
 375   II,     9.  1.  1    |                  and those who joined in 2004. The median rate of foetal
 376   II,     9.  1.  1    |              Harrigan JT, Vintzileos AM (2004): Maternal age and risk
 377   II,     9.  1.  1    |                Matern Fetal Neonatal Med 2004;15(3):193-7.~Castles A,
 378   II,     9.  1.  1    |                   983-90.~Cnattingius S (2004): The epidemiology of smoking
 379   II,     9.  1.  1    |               outcomes. Nicotine Tob Res 2004;6 Suppl 2:S125-40.~Cnattingius
 380   II,     9.  1.  1    |                RH, Elliott JP, Thorp JA (2004): Twins and triplets: the
 381   II,     9.  1.  1    |             infants. Am J Obstet Gynecol 2004;191(3):700-7.~Garne E (2001):
 382   II,     9.  1.  1    |                  KA, Wu YW, Croughan MS (2004): Perinatal outcomes in
 383   II,     9.  1.  1    |            meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kramer
 384   II,     9.  1.  1    |                     Lin HC, Xirasagar S (2004): Institutional factors
 385   II,     9.  1.  1    |             implications. Obstet Gynecol 2004;103(1):128-36.~Luke B, Brown
 386   II,     9.  1.  1    |                  88(2):283-93.~Magee BD (2004): Role of multiple births
 387   II,     9.  1.  1    |                  mortality. J Reprod Med 2004;49(10):812-6.~Maher J, Macfarlane
 388   II,     9.  1.  1    |                   Maher J, Macfarlane A (2004): Inequalities in infant
 389   II,     9.  1.  1    |                 1976-2000. Health Stat Q 2004(24):14-22.~Olausson PM,
 390   II,     9.  1.  2    |                per 1 000 births for 2000-2004 (Table 9.1.2.1). Total prevalence
 391   II,     9.  1.  2    |        congenital anomaly subgroups 2000-2004~ ~The average prevalence
 392   II,     9.  1.  2    |                  Cardiac Anomalies, 1992-2004.~ ~Perinatal mortality and
 393   II,     9.  1.  2    |               congenital anomalies, 2000-2004.~ ~Perinatal mortality due
 394   II,     9.  1.  2    |                 births, by country, 2000-2004~ ~The ratio of TOPFA to
 395   II,     9.  1.  2    |            births of Down Syndrome, 1992-2004~ ~Prenatal screening for
 396   II,     9.  1.  2    |                 in maternal age. In 2000-2004, differences in policy and
 397   II,     9.  1.  2    |               syndrome per country, 2000-2004~ ~Neural Tube Defects~ ~
 398   II,     9.  1.  2    |                Neural Tube Defects, 1992-2004~ ~During the 1980s and previously,
 399   II,     9.  1.  2    |                  al, 2005b). In the 2000-2004 period, the total prevalence
 400   II,     9.  1.  2    |               and 1.6 per 1 000 for 2000-2004 (EUROCAT, 2007), while rates
 401   II,     9.  1.  2    |                 per 1 000 births in 2000-2004 (Table 9.1.2.1). It is associated
 402   II,     9.  1.  2    |                 1 000 in the period 2000-2004, and two areas report a
 403   II,     9.  1.  2    |                are accessed (Dolk et al, 2004). Criteria may vary over
 404   II,     9.  1.  2    |         morbidity (Maher and Macfarlane, 2004). Older mothers and nulliparas
 405   II,     9.  1.  2    |             stillbirth (Canterino et al, 2004; Raymond et al, 1994; Reddy
 406   II,     9.  1.  2    |                  and Brown, 2007b; Magee 2004). This increased risk is
 407   II,     9.  1.  2    |                  al, 2005; Garite et al, 2004). Figures 9.T1.1 and 9.T1.
 408   II,     9.  1.  2    |                et al, 1999; Cnattingius, 2004). These effects concern
 409   II,     9.  1.  2    |        congenital anomaly risk (EUROCAT, 2004; Macintosh et al, 2006),
 410   II,     9.  1.  2    |                   Waller, 2007; EUROCAT, 2004). In the case of epilepsy
 411   II,     9.  1.  2    |                 Vrijheid, 2003; EUROCAT, 2004). To protect the fetus,
 412   II,     9.  1.  2    |                  countries (Garne et al, 2004; Garne et al, 2005). Such
 413   II,     9.  1.  2    |                  pregnancy (Green et al, 2004). The option of pregnancy
 414   II,     9.  1.  2    |             cause distress (Green et al, 2004).~ ~Public health initiatives
 415   II,     9.  1.  2    |                  Linzalone N, Madeddu A (2004): Surveillance of congenital
 416   II,     9.  1.  2    |                Siracusa. Epidemiol Prev. 2004 Mar-Apr;28(2):87-93.~Botto
 417   II,     9.  1.  2    |                 A, Calzolari E, Stone D (2004): "Towards the Effective
 418   II,     9.  1.  2    |                  Ulster.[www l]~EUROCAT (2004): "EUROCAT Special Report:
 419   II,     9.  1.  2    |               Loane M, de Vigan C et al (2004): “Prenatal Diagnostic Procedures
 420   II,     9.  1.  2    |                HL, Bryant LD, Cuckle HS (2004): Psychosocial aspects of
 421   II,     9.  1.  2    |        systematic review. HTA Assessment 2004; Vol 8, no. 33.~Hansen M,
 422   II,     9.  2.  1    |                 and Lithuania (WHO/HSBC, 2004).~ ~The World Health Organization (
 423   II,     9.  2.  2    |               the standard (Robine et al 2004). Organisations such as
 424   II,     9.  2.  2    |           countries of the EU (De Smedt, 2004). Moreover, the focus is
 425   II,     9.  2.  2    |            underage employment (WHO/HSBC 2004). These groups may be living
 426   II,     9.  2.  3    |                of asthma” (Masoli et al, 2004?), a report developed for
 427   II,     9.  2.  3    |                previous 12 months (HBSC, 2004). Unintentional injuries
 428   II,     9.  2.  3    |                  in Context study (HBSC, 2004) bullying occurring on average
 429   II,     9.  2.  3    |          reported among girls (WHO/HSBC, 2004). Bullying is one specific
 430   II,     9.  2.  3    |                  years of age (WHO/HSBC, 2004). For both biological and
 431   II,     9.  2.  3    |                report dieting (WHO/HSBC, 2004). In several countries of
 432   II,     9.  2.  3    |            endocrine disorders (WHO/HSBC 2004). Malta and Wales have among
 433   II,     9.  2.  3    |    muscle-enhancing activities (WHO/HSBC 2004). Self-assessment of BMI
 434   II,     9.  2.  3    |                   Neumark-Sztainer et al 2004).~ ~Mental Health: Mental
 435   II,     9.  2.  4    |                1996; Matharu and Ozanne, 2004; Ozanne et al, 2004).~ ~
 436   II,     9.  2.  4    |              Ozanne, 2004; Ozanne et al, 2004).~ ~Smoking. Smoking is
 437   II,     9.  2.  4    |                 society's terms (Jarvis, 2004). Data from ESPAD from 16
 438   II,     9.  2.  4    |              peaks in Denmark (WHO/HSBC, 2004; www rg interactive data) (
 439   II,     9.  2.  4    |               and Switzerland (WHO/HSBC, 2004), though in ESPAD data the
 440   II,     9.  2.  4    |                 sexual health (WHO/HSBC, 2004).~ ~Inadequate physical activity.
 441   II,     9.  2.  4    |                 media pressure (WHO/HSBC 2004). Although varying widely
 442   II,     9.  2.  4    |                 during the day (WHO/HSBC 2004).~ ~Disability. Regrettably,
 443   II,     9.  2.  5    |                  European children (WHO, 2004). It was developed at the
 444   II,     9.  2.  5    |                  Environment and Health (2004) on "The future for our
 445   II,     9.  2.  5    |              2010” (European Commission, 2004)~ ~
 446   II,     9.  2.  7    |                      accessed 28 January 2004):~ ~Council of the European
 447   II,     9.  2.  7    |                Brussels.~ ~De Smedt, M. (2004): Towards A Common Framework
 448   II,     9.  2.  7    |        Luxembourg~ ~European Commission (2004): Communication from the
 449   II,     9.  2.  7    |         Environment & Health Action Plan 2004-2010COM(2004) 416 final.
 450   II,     9.  2.  7    |               Action Plan 2004-2010COM(2004) 416 final. Available at:~htt ~ ~
 451   II,     9.  2.  7    |           Commission, Luxembourg~ ~HBSC (2004): Young people’s health
 452   II,     9.  2.  7    |                   Belgium)~ ~Jarvis, MJ (2004): Why People Smoke. British
 453   II,     9.  2.  7    |             Fabian D, Holt S, Beasley R (2004?): Global Burden of Asthma [
 454   II,     9.  2.  7    |                  Matharu, K., Ozanne, S (2004): The Fetal Origins of Disease
 455   II,     9.  2.  7    |                   NeoReviews Vol.5 No.12 2004 e522. American Academy of
 456   II,     9.  2.  7    |                  Story M; Fulkerson JA. (2004): Are family meal patterns
 457   II,     9.  2.  7    |            Health; 35(5):350-9, November 2004~ ~Ozanne SE, Fernandez-Twinn
 458   II,     9.  2.  7    |           Available at:~htt ~ ~WHO/HBSC (2004); Young people’s health
 459   II,     9.  2.  7    |              Health; WHO, Geneva.~ ~WHO (2004): Children's Environment
 460   II,     9.  3.  1    |           countries of the EU (De Smedt, 2004).~ ~This section is also
 461   II,     9.  3.  1    |           European Mental Health Report (2004) and helps explain why men
 462   II,     9.  3.  1    |               which data was reported in 2004 (excluding Italy and Spain).
 463   II,     9.  3.  1    |            survival rates (UNAIDS et al, 2004).~ ~Sexually Transmitted
 464   II,     9.  3.  1    |          malignancy (Fenton and Lowndes, 2004). Nevertheless, about 70
 465   II,     9.  3.  1    |              disease (Lim & Fitzpatrick, 2004); the treatment of prostate
 466   II,     9.  3.  1    |             population worldwide (Kvien, 2004). As the disease increases
 467   II,     9.  3.  1    |                 921 - 931.~ ~De Smedt M (2004): Towards A Common Framework
 468   II,     9.  3.  1    |              Fenton K A and Lowndes C M (2004): Recent trends in the epidemiology
 469   II,     9.  3.  1    |                 255-263; doi:10.1136/sti.2004.009415~ ~Forsgren L, Beghi
 470   II,     9.  3.  1    |                  Lim LS, Fitzpatrick RD (2004): Osteoporosis in Men. In
 471   II,     9.  3.  1    |                 Tsuboi K, Dennerstein L (2004); Prevalence of eating disorders:
 472   II,     9.  3.  1    |               UNAIDS, UNFPA, and UNIFEM (2004): Women and HIV/AIDS Confronting
 473   II,     9.  3.  2    |                to 26 per 100 000 in 2002-2004, still the highest among
 474   II,     9.  3.  2    |                 two-year period 2003 and 2004, there is a substantial
 475   II,     9.  3.  2    |           selected EUGLOREH countries in 2004-2006~ ~For a few countries -
 476   II,     9.  3.  2    |                 1989; Lin and Xirasagar, 2004). Caesarean delivery is
 477   II,     9.  3.  2    |                 infertility problems. In 2004, up to 3-4% of newborns
 478   II,     9.  3.  2    |             Member States entering EU in 2004, the percentage is even
 479   II,     9.  3.  2    |                 al, 2002; Jackson et al, 2004). Improved antenatal screening
 480   II,     9.  3.  2    |              Harrigan JT, Vintzileos AM (2004): Maternal age and risk
 481   II,     9.  3.  2    |                Matern Fetal Neonatal Med 2004;15(3):193-7.~ ~Castles A,
 482   II,     9.  3.  2    |                  16-21.~ ~Cnattingius S (2004): The epidemiology of smoking
 483   II,     9.  3.  2    |               outcomes. Nicotine Tob Res 2004;6 Suppl 2:S125-40.~ ~De
 484   II,     9.  3.  2    |                RH, Elliott JP, Thorp JA (2004): Twins and triplets: the
 485   II,     9.  3.  2    |             infants. Am J Obstet Gynecol 2004;191(3):700-7.~ ~Garne E (
 486   II,     9.  3.  2    |                  KA, Wu YW, Croughan MS (2004): Perinatal outcomes in
 487   II,     9.  3.  2    |            meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kahn B,
 488   II,     9.  3.  2    |                     Lin HC, Xirasagar S (2004): Institutional factors
 489   II,     9.  3.  2    |             implications. Obstet Gynecol 2004;103(1):128-36.~ ~London:
 490   II,     9.  3.  2    |            Livinstone, 1981.~ ~Magee BD (2004): Role of multiple births
 491   II,     9.  3.  2    |                  mortality. J Reprod Med 2004;49(10):812-6.~ ~Maher J,
 492   II,     9.  3.  2    |                   Maher J, Macfarlane A (2004): Inequalities in infant
 493   II,     9.  3.  2    |                 1976-2000. Health Stat Q 2004(24):14-22.~ ~Marret S, Ancel
 494   II,     9.  3.  3    |              World Health Assembly (WHO, 2004)~ ~Risky sexual behaviour
 495   II,     9.  3.  3    |              from Denmark (Kangas et al, 2004), France (Gremy and Beltzer,
 496   II,     9.  3.  3    |               France (Gremy and Beltzer, 2004), Finland (Haavio-Mannila
 497   II,     9.  3.  3    |                   Portugal (Amaro et al, 2004), Slovenia (Klavs et al,
 498   II,     9.  3.  3    |                for Europe (Currie et al, 2004). HBSC surveys have started
 499   II,     9.  3.  3    |                   Fig. 1) (Currie et al, 2004). The gender differences
 500   II,     9.  3.  3    |                 age of 15 (Currie at al, 2004). In Romania (Serbanescu